In contrast, RE treatment mitigated T2DM-induced impairments in glucose homeostasis, improving both glucose tolerance and insulin tolerance compared to T2DM-SED mice (Figure 1F–I). This evidence concerns the gene INS and type 2 diabetes mellitus.